Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma | Zendy

Tatsuya Yamashita | Zendy; Kuniaki Arai | Zendy; Hajime Sunagozaka | Zendy; Teruyuki Ueda | Zendy; Takeshi Terashima | Zendy; Taro Yamashita | Zendy; Eishiro Mizukoshi | Zendy; Akito Sakai | Zendy; Yasunari Nakamoto | Zendy; Masao Honda | Zendy; Shuichi Kaneko | Zendy

Open Access

Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

Author(s) -

Tatsuya Yamashita,

Kuniaki Arai,

Hajime Sunagozaka,

Teruyuki Ueda,

Takeshi Terashima,

Taro Yamashita,

Eishiro Mizukoshi,

Akito Sakai,

Yasunari Nakamoto,

Masao Honda,

Shuichi Kaneko

Publication year - 2011

Publication title -

oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.987

H-Index - 98

eISSN - 1423-0232

pISSN - 0030-2414

DOI - 10.1159/000334439

Subject(s) - fluorouracil , medicine , gastroenterology , hepatocellular carcinoma , cisplatin , chemotherapy , toxicity , interferon alfa , urology , cancer , immunotherapy

This randomized phase II trial compared the response rates to treatment with interferon (IFN) combined with hepatic arterial infusion of fluorouracil (FU) plus cisplatin (CDDP) or FU alone in patients with advanced hepatocellular carcinoma (HCC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research